NACDS: Pharmacists as Vaccinators are Key in Whooping Cough Battle

Published Online: Tuesday, August 7, 2012


August 07, 2012

NACDS' Pharmacy Care and Patient Advocacy Department takes message public via media

Alexandria, Va. — Reflecting the value of community pharmacy, the National Association of Chain Drug Stores (NACDS) is answering the call of public health authorities to promote vaccinations in the battle against whooping cough, or pertussis. Kathleen Jaeger, NACDS’ senior vice president of pharmacy care and patient advocacy, is spreading this message amid a growing national outbreak of the highly-contagious respiratory disease.

In a letter addressed to “pharmacists and community vaccinators,” the Centers for Disease Control and Prevention (CDC) asked them to help raise awareness of whooping cough vaccinations, because “as trusted health care professionals, research shows that [their] recommendation to receive needed vaccines is vital.”

To exert a leadership role in this initiative, NACDS is featuring Jaeger, a pharmacist, in an online, print and radio media outreach effort to bring attention to the outbreak and to note the accessible and professional solution that community pharmacies provide. Through the use of op-eds, interviews, news releases and other communications vehicles, Jaeger will concentrate her efforts in Washington State, where the CDC has declared a whooping cough epidemic, and in Minnesota and Wisconsin, which have the next highest rates of reported incidences.

“With their extensive expertise, pharmacists are uniquely positioned to promote and provide vaccines to patients. We appreciate the CDC’s recognition of community pharmacy’s important role in the healthcare delivery system, and we stand ready to help protect patients and their loved ones from this disease.”

The CDC is reporting a three-fold increase in pertussis rates in over a dozen states. Pharmacists can administer the Tdap vaccine - which protects against pertussis (whooping cough), tetanus, and diphtheria in adults - in 43 states, including Minnesota, Washington State and Wisconsin.

The CDC is recommending that adults who come into close contact with young infants - parents, grandparents, caretakers and other adults – receive a dose of the vaccine, known as Tdap, at least two weeks prior to contact. The vaccination will help protect newborns, infants and school-age children against tetanus, diphtheria and pertussis. The CDC also recommends that pregnant women receive the vaccination after 20 weeks of pregnancy and to receive the influenza vaccine anytime during pregnancy.

For more information about the whooping cough vaccine and other recommended vaccines for adults and children, visit the CDC website.

Latest Articles
Mylan has announced the US launch of clozapine orally disintegrating tablets, 25 mg and 100 mg, the generic version of Jazz Pharmaceutical’s FazaClo.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about some safeguards pharmacists can implement.
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Latest Issues